News Focus
News Focus
Followers 147
Posts 26153
Boards Moderated 0
Alias Born 04/08/2004

Re: frrol post# 233356

Saturday, 02/01/2020 3:19:08 PM

Saturday, February 01, 2020 3:19:08 PM

Post# of 516949
Nonsense

Show us in writing that there are such restrictions.

The issue we're talking about is publicly stating them as a trial agent. There are even restrictions on privately stating them among each other. Those restrictions are not absolute, but they are extensive and based on important reasons having to do with maintaining blinds and minimizing bias.



As I stated:

He has NOT set the expectation that trial participants.

The information regarding dizziness has been public information for the Anavex trials and other Alzheimer's trials for years. This is NOT new information with this article.


Tolerability: Maximum tolerated dose (MTD) of ANAVEX 2-73 was defined as 55mg. Observed adverse events at doses above the MTD included dizziness and headache, which were moderate in severity and reversible. These side effects are often seen with drugs that target CNS conditions, including Alzheimer’s disease.




https://www.anavex.com/anavex-announces-positive-phase-1-data-for-anavex-2-73-lead-candidate-for-the-treatment-of-alzheimers/

**************************************************************

Aricept (donepezil hydrochloride) is a cholinesterase inhibitor that reduces or prevents acetylcholine breakdown in brain tissue. Aricept is used to treat mild to moderate dementia like that found in patients with Alzheimer's disease. Aricept is not a cure; it reduces symptoms. Aricept is available as a generic. Common side effects of Aricept include

feeling unwell (malaise),
appetite loss,
weight loss,
sleep problems (insomnia),
muscle cramps,
tiredness,
drowsiness,
dizziness,
weakness,
shakiness (tremor),
itchy skin,
nausea,
vomiting, or
diarrhea.

Good luck and GOD bless,

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News